This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2001 May;119(5):1297-9.

doi: 10.1378/chest.119.5.1297.

Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ

PMID: 11348928
DOI: 10.1378/chest.119.5.1297

Comparative Study

Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ

M R Sears. Chest. 2001 May.

. 2001 May;119(5):1297-9.

doi: 10.1378/chest.119.5.1297.

Author

PMID: 11348928
DOI: 10.1378/chest.119.5.1297

No abstract available

PubMed Disclaimer

Comment in

MIASMA: asthma exacerbation reduction with salmeterol.
Shrewsbury S, Pyke S. Shrewsbury S, et al. Chest. 2002 Mar;121(3):1002-4. doi: 10.1378/chest.121.3.1002-a. Chest. 2002. PMID: 11888994 No abstract available.

Comment on

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients.
Cloosterman SG, Bijl-Hofland ID, van Herwaarden CL, Akkermans RP, van Den Elshout FJ, Folgering HT, van Schayck CP. Cloosterman SG, et al. Chest. 2001 May;119(5):1306-15. doi: 10.1378/chest.119.5.1306. Chest. 2001. PMID: 11348933 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information